Comments
Loading...

Arcellx Analyst Ratings

ACLXNASDAQ
Logo brought to you by Benzinga Data
$65.55
0.020.03%
At close: -
$65.55
0.000.00%
After Hours: May 2, 4:00 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$136.00
Lowest Price Target1
$39.00
Consensus Price Target1
$99.79

Arcellx Analyst Ratings and Price Targets | NASDAQ:ACLX | Benzinga

Arcellx Inc has a consensus price target of $99.79 based on the ratings of 18 analysts. The high is $136 issued by Truist Securities on November 12, 2024. The low is $39 issued by SVB Leerink on March 30, 2023. The 3 most-recent analyst ratings were released by UBS, HC Wainwright & Co., and Needham on December 10, 2024, respectively. With an average price target of $111.33 between UBS, HC Wainwright & Co., and Needham, there's an implied 69.84% upside for Arcellx Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
9
Nov 24
4
Dec 24
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

UBS
HC Wainwright & Co.
Needham
Truist Securities
Piper Sandler

1calculated from analyst ratings

Analyst Ratings for Arcellx

Buy NowGet Alert
12/10/2024Buy Now73.91%UBS
Ashwani Verma42%
$106 → $114MaintainsBuyGet Alert
12/10/2024Buy Now75.44%HC Wainwright & Co.
Emily Bodnar38%
$115 → $115ReiteratesBuy → BuyGet Alert
12/10/2024Buy Now60.18%Needham
Gil Blum51%
$105 → $105ReiteratesBuy → BuyGet Alert
12/09/2024Buy Now60.18%Needham
Gil Blum51%
$105 → $105ReiteratesBuy → BuyGet Alert
11/12/2024Buy Now107.48%Truist Securities
Asthika Goonewardene41%
$87 → $136MaintainsBuyGet Alert
11/08/2024Buy Now75.44%HC Wainwright & Co.
Emily Bodnar38%
$95 → $115MaintainsBuyGet Alert
11/08/2024Buy Now75.44%Piper Sandler
Biren Amin42%
$91 → $115MaintainsOverweightGet Alert
11/08/2024Buy Now60.18%Needham
Gil Blum51%
$96 → $105MaintainsBuyGet Alert
11/06/2024Buy Now61.71%Morgan Stanley
Judah Frommer66%
$81 → $106MaintainsOverweightGet Alert
11/06/2024Buy Now52.56%B of A Securities
Jason Gerberry60%
$84 → $100MaintainsBuyGet Alert
11/06/2024Buy Now61.71%Baird
Jack Allen 35%
$77 → $106MaintainsOutperformGet Alert
11/06/2024Buy Now44.93%HC Wainwright & Co.
Emily Bodnar38%
$80 → $95MaintainsBuyGet Alert
11/06/2024Buy Now46.45%Needham
Gil Blum51%
$96 → $96ReiteratesBuy → BuyGet Alert
10/31/2024Buy Now46.45%Needham
Gil Blum51%
$96 → $96ReiteratesBuy → BuyGet Alert
10/22/2024Buy Now46.45%Needham
Gil Blum51%
$81 → $96MaintainsBuyGet Alert
10/18/2024Buy Now86.12%Stifel
Benjamin Burnett46%
$83 → $122MaintainsBuyGet Alert
10/17/2024Buy Now75.44%Canaccord Genuity
John Newman45%
$85 → $115MaintainsBuyGet Alert
09/09/2024Buy Now—Cantor Fitzgerald
Josh Schimmer56%
—Reiterates → OverweightGet Alert
09/03/2024Buy Now—Cantor Fitzgerald
Rick Bienkowski27%
—Initiates → OverweightGet Alert
08/09/2024Buy Now23.57%Needham
Gil Blum51%
$81 → $81ReiteratesBuy → BuyGet Alert
07/22/2024Buy Now29.67%Canaccord Genuity
John Newman45%
$85 → $85MaintainsBuyGet Alert
06/18/2024Buy Now32.72%Truist Securities
Asthika Goonewardene41%
$87 → $87MaintainsBuyGet Alert
05/31/2024Buy Now6.79%Piper Sandler
Biren Amin42%
→ $70Initiates → OverweightGet Alert
05/15/2024Buy Now26.62%Stifel
Benjamin Burnett46%
$82 → $83MaintainsBuyGet Alert
05/14/2024Buy Now29.67%Evercore ISI Group
Cory Kasimov70%
→ $85Initiates → OutperformGet Alert
05/13/2024Buy Now22.04%HC Wainwright & Co.
Emily Bodnar38%
$82 → $80MaintainsBuyGet Alert
05/10/2024Buy Now23.57%Needham
Gil Blum51%
$81 → $81ReiteratesBuy → BuyGet Alert
05/07/2024Buy Now23.57%Needham
Gil Blum51%
$81 → $81ReiteratesBuy → BuyGet Alert
04/11/2024Buy Now23.57%Needham
Gil Blum51%
$81 → $81ReiteratesBuy → BuyGet Alert
03/18/2024Buy Now23.57%Needham
Gil Blum51%
$72 → $81MaintainsBuyGet Alert
03/14/2024Buy Now25.1%Stifel
Benjamin Burnett46%
→ $82ReiteratesBuy → BuyGet Alert
03/07/2024Buy Now23.57%Morgan Stanley
Judah Frommer66%
→ $81Initiates → OverweightGet Alert
03/05/2024Buy Now32.72%Truist Securities
Asthika Goonewardene41%
$57 → $87MaintainsBuyGet Alert
02/29/2024Buy Now25.1%HC Wainwright & Co.
Emily Bodnar38%
$60 → $82MaintainsBuyGet Alert
02/29/2024Buy Now29.67%Canaccord Genuity
John Newman45%
$66 → $85MaintainsBuyGet Alert
02/29/2024Buy Now11.37%Barclays
Carter Gould60%
$62 → $73MaintainsOverweightGet Alert
02/29/2024Buy Now9.84%Needham
Gil Blum51%
$71 → $72MaintainsBuyGet Alert
02/29/2024Buy Now17.47%Baird
Jack Allen 35%
$63 → $77MaintainsOutperformGet Alert
01/04/2024Buy Now8.31%Needham
Gil Blum51%
$65 → $71MaintainsBuyGet Alert
12/19/2023Buy Now0.69%Scotiabank
George Farmer41%
→ $66Initiates → Sector OutperformGet Alert
12/12/2023Buy Now-0.84%Needham
Gil Blum51%
$65 → $65ReiteratesBuy → BuyGet Alert
12/11/2023Buy Now-0.84%Needham
Gil Blum51%
$60 → $65MaintainsBuyGet Alert
11/16/2023Buy Now0.69%Canaccord Genuity
John Newman45%
$49 → $66MaintainsBuyGet Alert
11/16/2023Buy Now-5.42%Barclays
Carter Gould60%
$49 → $62MaintainsOverweightGet Alert
11/15/2023Buy Now-8.47%HC Wainwright & Co.
Emily Bodnar38%
$50 → $60MaintainsBuyGet Alert
11/15/2023Buy Now-8.47%Needham
Gil Blum51%
$51 → $60MaintainsBuyGet Alert
10/30/2023Buy Now—TD Cowen
Tyler Van Buren46%
—Initiates → OutperformGet Alert
10/17/2023Buy Now-20.67%UBS
Ashwani Verma42%
→ $52Initiates → BuyGet Alert
08/15/2023Buy Now-20.67%Baird
Jack Allen 35%
$40 → $52MaintainsOutperformGet Alert
08/15/2023Buy Now-20.67%Stifel
Benjamin Burnett46%
$54 → $52MaintainsBuyGet Alert
08/15/2023Buy Now-22.2%Needham
Gil Blum51%
$51 → $51ReinstatesBuy → BuyGet Alert
08/15/2023Buy Now-23.72%HC Wainwright & Co.
Emily Bodnar38%
$49 → $50MaintainsBuyGet Alert
06/23/2023Buy Now-22.2%Needham
Gil Blum51%
→ $51ReiteratesBuy → BuyGet Alert
06/21/2023Buy Now-25.25%Canaccord Genuity
John Newman45%
$49 → $49ReiteratesBuy → BuyGet Alert
06/21/2023Buy Now-25.25%HC Wainwright & Co.
Emily Bodnar38%
→ $49ReiteratesBuy → BuyGet Alert
06/20/2023Buy Now—Guggenheim
Kelsey Goodwin34%
—MaintainsBuyGet Alert
06/20/2023Buy Now-25.25%HC Wainwright & Co.
Emily Bodnar38%
→ $49Reiterates → BuyGet Alert
06/20/2023Buy Now-13.04%Truist Securities
Asthika Goonewardene41%
$60 → $57MaintainsBuyGet Alert
06/20/2023Buy Now-22.2%Needham
Gil Blum51%
→ $51ReiteratesBuy → BuyGet Alert
05/18/2023Buy Now-8.47%Truist Securities
Asthika Goonewardene41%
→ $60Initiates → BuyGet Alert
05/10/2023Buy Now-23.72%B of A Securities
Jason Gerberry60%
$39 → $50MaintainsBuyGet Alert
05/09/2023Buy Now-25.25%HC Wainwright & Co.
Emily Bodnar38%
$40 → $49MaintainsBuyGet Alert
05/09/2023Buy Now-22.2%Needham
Gil Blum51%
$35 → $51MaintainsBuyGet Alert
05/09/2023Buy Now-25.25%Barclays
Carter Gould60%
$38 → $49MaintainsOverweightGet Alert
04/26/2023Buy Now-25.25%Canaccord Genuity
John Newman45%
$40 → $49MaintainsBuyGet Alert
04/24/2023Buy Now-11.52%Guggenheim
Kelsey Goodwin34%
$45 → $58MaintainsBuyGet Alert
04/19/2023Buy Now-38.98%Canaccord Genuity
John Newman45%
$34 → $40MaintainsBuyGet Alert
04/14/2023Buy Now-40.5%Baird
Jack Allen 35%
→ $39Initiates → OutperformGet Alert
04/13/2023Buy Now-40.5%Baird
Jack Allen 35%
→ $39Initiates → OutperformGet Alert
03/30/2023Buy Now-46.61%Needham
Gil Blum51%
→ $35Reiterates → BuyGet Alert
03/30/2023Buy Now-40.5%SVB Leerink
Daina Graybosch43%
$35 → $39MaintainsOutperformGet Alert
03/30/2023Buy Now-38.98%HC Wainwright & Co.
Emily Bodnar38%
$42 → $40MaintainsBuyGet Alert
03/14/2023Buy Now-34.4%Stifel
Benjamin Burnett46%
→ $43Initiates → BuyGet Alert
02/13/2023Buy Now-35.93%HC Wainwright & Co.
Emily Bodnar38%
→ $42Initiates → BuyGet Alert
12/13/2022Buy Now-43.55%B of A Securities
Jason Gerberry60%
→ $37Reinstates → BuyGet Alert
12/12/2022Buy Now-46.61%Needham
Gil Blum51%
$31 → $35MaintainsBuyGet Alert
12/12/2022Buy Now-42.03%Barclays
Carter Gould60%
$25 → $38MaintainsOverweightGet Alert
10/31/2022Buy Now-45.08%Guggenheim
Kelsey Goodwin34%
→ $36Initiates → BuyGet Alert
10/27/2022Buy Now-52.71%Needham
Gil Blum51%
→ $31Initiates → BuyGet Alert
07/20/2022Buy Now-51.18%Canaccord Genuity
John Newman45%
→ $32Initiates → BuyGet Alert
06/23/2022Buy Now-42.03%SVB Leerink
Daina Graybosch43%
$47 → $38MaintainsOutperformGet Alert
05/13/2022Buy Now-28.3%SVB Leerink
Daina Graybosch43%
$44 → $47MaintainsOutperformGet Alert

FAQ

Q

What is the target price for Arcellx (ACLX) stock?

A

The latest price target for Arcellx (NASDAQ:ACLX) was reported by UBS on December 10, 2024. The analyst firm set a price target for $114.00 expecting ACLX to rise to within 12 months (a possible 73.91% upside). 28 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Arcellx (ACLX)?

A

The latest analyst rating for Arcellx (NASDAQ:ACLX) was provided by UBS, and Arcellx maintained their buy rating.

Q

When was the last upgrade for Arcellx (ACLX)?

A

There is no last upgrade for Arcellx

Q

When was the last downgrade for Arcellx (ACLX)?

A

There is no last downgrade for Arcellx.

Q

When is the next analyst rating going to be posted or updated for Arcellx (ACLX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Arcellx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Arcellx was filed on December 10, 2024 so you should expect the next rating to be made available sometime around December 10, 2025.

Q

Is the Analyst Rating Arcellx (ACLX) correct?

A

While ratings are subjective and will change, the latest Arcellx (ACLX) rating was a maintained with a price target of $106.00 to $114.00. The current price Arcellx (ACLX) is trading at is $65.55, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch